Palo Alto Investors LP Long-Term Concentrated

CIK: 0001306923 · Show all filings

Period: Q2 2013 (Next →)

Filing Date: Aug 14, 2013

Total Value ($000): $847,287 (100.0% shares, 0.0% debt)

Holdings (32)

Onyx Pharmaceuticals, Inc. 13.6%
Value ($000) $115,046 Shares 1,325,115 Est. Cost $86.82 Unrealized
ViroPharma Incorporated 13.4%
Value ($000) $113,707 Shares 3,968,818 Est. Cost $28.65 Unrealized
Cyberonics, Inc. 11.4%
Value ($000) $96,808 Shares 1,863,118 Est. Cost $51.96 Unrealized
UTHR United Therapeutics Corp 7.0%
Value ($000) $59,289 Shares 900,778 Est. Cost $64.42 Unrealized 0.0%
Abiomed Inc. 5.9%
Value ($000) $50,006 Shares 2,319,398 Est. Cost $21.56 Unrealized
Auxilium Pharmaceuticals, Inc. 5.6%
Value ($000) $47,362 Shares 2,847,842 Est. Cost $16.63 Unrealized
BMRN Biomarin Pharmaceuticals, Inc 5.2%
Value ($000) $43,874 Shares 787,119 Est. Cost $62.32 Unrealized 0.0%
AMAG Pharmaceuticals, Inc. 4.4%
Value ($000) $37,399 Shares 1,680,871 Est. Cost $22.25 Unrealized
Cubist Pharmaceuticals, Inc. 4.3%
Value ($000) $36,547 Shares 756,821 Est. Cost $48.29 Unrealized
Sequenom Inc. 4.1%
Value ($000) $34,533 Shares 8,202,692 Est. Cost $4.21 Unrealized
STAA STAAR Surgical Company 3.8%
Value ($000) $32,595 Shares 3,211,318 Est. Cost $8.10 Unrealized 0.0%
Questcor Pharmaceuticals, Inc. 3.7%
Value ($000) $31,640 Shares 696,297 Est. Cost $45.44 Unrealized
VNDA Vanda Pharmaceutical Inc. 2.3%
Value ($000) $19,246 Shares 2,381,876 Est. Cost $6.73 Unrealized 0.0%
Alimera Sciences, Inc. 2.1%
Value ($000) $17,739 Shares 3,634,984 Est. Cost $4.88 Unrealized
Momenta Pharmaceuticals, Inc. 2.1%
Value ($000) $17,697 Shares 1,175,076 Est. Cost $15.06 Unrealized
Intermune Inc. 2.0%
Value ($000) $17,080 Shares 1,775,485 Est. Cost $9.62 Unrealized
Rigel Pharmaceuticals Inc. 1.6%
Value ($000) $13,145 Shares 3,935,576 Est. Cost $3.34 Unrealized
FOLD Amicus Therapeutics, Inc. 1.3%
Value ($000) $10,770 Shares 4,622,230 Est. Cost $3.07 Unrealized 0.0%
Anacor Pharmaceuticals, Inc. 1.1%
Value ($000) $9,043 Shares 1,617,651 Est. Cost $5.59 Unrealized
AVEO Pharmaceuticals, Inc. 1.0%
Value ($000) $8,773 Shares 3,509,205 Est. Cost $2.50 Unrealized
QLT Inc. 1.0%
Value ($000) $8,563 Shares 1,950,636 Est. Cost $4.39 Unrealized
Savient Pharmaceuticals, Inc. 0.6%
Value ($000) $5,457 Shares 9,744,833 Est. Cost $0.56 Unrealized
INSM Insmed, Inc. 0.4%
Value ($000) $3,185 Shares 266,299 Est. Cost $10.22 Unrealized 0.0%
Aegerion Pharmaceuticals Inc. 0.4%
Value ($000) $3,106 Shares 49,040 Est. Cost $63.34 Unrealized
Cytokinetics Inc. 0.4%
Value ($000) $3,026 Shares 261,544 Est. Cost $11.57 Unrealized
Spectrum Pharmaceuticals Inc. 0.3%
Value ($000) $2,954 Shares 395,985 Est. Cost $7.46 Unrealized
Kythera BioPharm CMN 0.3%
Value ($000) $2,332 Shares 86,201 Est. Cost $27.05 Unrealized
Xoma Ltd. 0.2%
Value ($000) $1,897 Shares 522,683 Est. Cost $3.63 Unrealized
Hyperion Therapeutics 0.2%
Value ($000) $1,839 Shares 83,600 Est. Cost $22.00 Unrealized
PRTA Prothena Corp PLC 0.1%
Value ($000) $1,143 Shares 88,500 Est. Cost $9.30 Unrealized 0.0%
Dendreon Corp 0.1%
Value ($000) $856 Shares 207,800 Est. Cost $4.12 Unrealized
NxStage Medical, Inc. 0.1%
Value ($000) $630 Shares 44,129 Est. Cost $14.28 Unrealized